QuickView for neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (biogroup)

1. Drug target sets for approved compounds
2. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
5. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens

There were no matches for neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential

There were no clinical trials for neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential